T1	Participants 14 111	racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
T2	Participants 376 448	The Prostate, Colorectal, Lung and Ovarian (PLCO) Cancer Screening Trial
T3	Participants 557 621	Subjects were recruited at 10 U.S. centers between 1993 and 2001
T4	Participants 543 555	PLCO cancers
T5	Participants 125 199	Minority populations in the United States, especially blacks and Hispanics
T6	Participants 315 332	ethnic minorities
T7	Participants 687 693	blacks
T8	Participants 756 765	Hispanics
T9	Participants 775 905	Among almost 155,000 subjects enrolled in PLCO, minority enrollment was as follows: black (5.0%), Hispanic (1.8%) and Asian (3.6%)
T10	Participants 907 1443	This compares to an age-eligible population in the combined catchment areas of the PLCO centers that was 14.0% black, 2.9% Hispanic and 5.4% Asian, and an age-eligible population across the U.S. that was 9.5% black, 6.5% Hispanic and 3.0% Asian. About half (45%) of Hispanics were recruited at the center with the special Hispanic recruitment effort. Seventy percent of blacks were recruited at two centers; the one with the major special recruitment effort and a center in Detroit whose catchment area was 20% black among age-eligibles
